Skip to content

The Assessment of Sara Pariksha On Amavata(Rheumatoidarthritis) Patients-The Observational Study

The Assessment Of Sara Pariksha On Amavata(Rheumatoid Arthritis) Patients- An Observational Study - The Assessment Of Sara Pariksha On Amavata(Rheumatoid Arthritis) Patients- An Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/060272
Enrollment
100
Registered
2023-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M04-M04- Autoinflammatory syndromes Health Condition 2: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

PT KHUSILAL SHARMA GOVT AYURVEDA COLLEGE INSTITUTE BHOPAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient having the sign and symptoms of Rheumatoid Arthritis (Amavata) 2. Patient who fulfilled the revised criteria for the diagnosis of Rheumatoid Arthritis (American Rheumatic Association 2010). 3. Patient of either sex between the Age group of 21-60 years. 4. Patients willing to give written informed consent for the participation in the proposed Research work.

Exclusion criteria

Exclusion criteria: 1. Patient not fulfilling the inclusion criteria 2. Pregnant and lactating women 3. Patients having history of systemic complicated disease like. Tuberculosis. Diabetes HIV any malignancy etc 4. Patients not willing for participation in research activity with written informed consent

Design outcomes

Primary

MeasureTime frame
It is expected that at the end of the observational study we would be able to explain the predominance of a specific sara in Amavata rogi. Sara Pariksha helpful in diagnostic & prognostic aspect of Amavata. It is further expected that this study will establish a landmark for researchers & practitioners for use of sara in Amavata patients to establish their strength.Timepoint: 12 Months

Secondary

MeasureTime frame
It is further expected that this study will establish a landmark for researchers & practitioners for use of sara in Amavata patients to establish their strength.Timepoint: 12 Months

Countries

India

Contacts

Public ContactDR AKANKSHA GWALE

PT. KHUSHILAL SHARMA GOVT. AYURVEDA COLLEGE & INSTITUTE BHOPAL

rajeshjain1075@yahoo.com9827730455

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026